IN2014DN07895A - - Google Patents

Info

Publication number
IN2014DN07895A
IN2014DN07895A IN7895DEN2014A IN2014DN07895A IN 2014DN07895 A IN2014DN07895 A IN 2014DN07895A IN 7895DEN2014 A IN7895DEN2014 A IN 7895DEN2014A IN 2014DN07895 A IN2014DN07895 A IN 2014DN07895A
Authority
IN
India
Prior art keywords
drug
exchange resin
cation exchange
present
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Vinod Kumar Arora
Jatin Khurana
Deepak Gaikwad
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN7895DEN2014 priority Critical patent/IN2014DN07895A/en
Publication of IN2014DN07895A publication Critical patent/IN2014DN07895A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
IN7895DEN2014 2012-02-21 2013-02-21 IN2014DN07895A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN7895DEN2014 IN2014DN07895A (es) 2012-02-21 2013-02-21

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN496DE2012 2012-02-21
PCT/IB2013/051432 WO2013124818A1 (en) 2012-02-21 2013-02-21 Taste masked dispersible tablets
IN7895DEN2014 IN2014DN07895A (es) 2012-02-21 2013-02-21

Publications (1)

Publication Number Publication Date
IN2014DN07895A true IN2014DN07895A (es) 2015-04-24

Family

ID=54261187

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7895DEN2014 IN2014DN07895A (es) 2012-02-21 2013-02-21

Country Status (10)

Country Link
US (1) US20150031647A1 (es)
EP (1) EP2816997A1 (es)
CN (1) CN104203212A (es)
AP (1) AP2014007934A0 (es)
AU (1) AU2013223705A1 (es)
CA (1) CA2865312A1 (es)
IN (1) IN2014DN07895A (es)
MX (1) MX2014010038A (es)
SG (1) SG11201405053SA (es)
WO (1) WO2013124818A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6577024B2 (ja) * 2014-05-08 2019-09-18 シーティーシー バイオ インコーポレイテッド 味が遮蔽されたクロミプラミン含有経口投与用薬学製剤
CN112353802A (zh) * 2020-11-26 2021-02-12 山东诚创蓝海医药科技有限公司 一种富马酸伏诺拉生掩味组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032245A1 (en) 2000-07-27 2002-03-14 Lyn Hughes Resinate composition
US20040067216A1 (en) 2002-02-22 2004-04-08 Karki Shyam B. Hiv protease inhibitors supported on cation exchange resins for oral administration
EP2198857A1 (en) * 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
WO2011080683A1 (en) * 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Taste masked dosage forms of bitter tasting anti-retroviral drugs

Also Published As

Publication number Publication date
AP2014007934A0 (en) 2014-09-30
MX2014010038A (es) 2014-12-05
US20150031647A1 (en) 2015-01-29
SG11201405053SA (en) 2014-09-26
CN104203212A (zh) 2014-12-10
WO2013124818A1 (en) 2013-08-29
CA2865312A1 (en) 2013-08-29
AU2013223705A1 (en) 2014-09-11
EP2816997A1 (en) 2014-12-31

Similar Documents

Publication Publication Date Title
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
PH12016501122A1 (en) Delayed release compositions of linaclotide
MX366317B (es) Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias.
IN2015DN03984A (es)
EP3102188A4 (en) Novel disintegration systems for pharmaceutical dosage forms
MX2015009045A (es) Composiciones y metodos para tratar el dolor severo.
PH12016501841A1 (en) Immunosuppressant formulation
HK1205462A1 (en) Pharmaceutical preparation containing an antivirally active dihydroquinazoline derivative
IN2013MU03583A (es)
IN2014DN06966A (es)
IL243786A0 (en) A drug that contains a pharmaceutical combination of dolutegravir, emtricitabine and tenofovir
IN2014MN02236A (es)
MX2016008369A (es) Composicion farmaceutica que incluye palonosetron.
WO2014033526A9 (en) Pharmaceutical compositions of etoricoxib
HUP1300647A2 (hu) Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik
AP2015008208A0 (en) Pharmaceutical administration forms comprising
IN2013MU01985A (es)
MX2016002560A (es) Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir.
IN2013MU01111A (es)
TWI800759B (zh) 醫藥劑型
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
MX2014006201A (es) Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse.
IN2014DN07895A (es)
PH12016500847A1 (en) Multi-particulate drug delivery system
IN2013CH04314A (es)